StonvexLoading…
StonvexCore line items from HY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-03 | Q1 2026 2026-03-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 | Q1 2025 2025-03-31 |
|---|---|---|---|---|---|
Revenue | $828.76M | $0.00 | $0.00 | $0.00 | $0.00 |
Operating Income | Not available | $-28.00M | $15.10M | $12.80M | $21.30M |
Net Income | Not available | $-30.50M | $-7.60M | $-5.30M | $8.60M |
EPS (Diluted) | $-1.53 | $-1.71 | $-0.43 | $-0.30 | $0.48 |
Total Assets | Not available | $1.96B | $2.06B | $2.08B | $2.06B |
Total Liabilities | Not available | $1.51B | $1.51B | $1.51B | $1.53B |
Cash & Equivalents | Not available | $81.80M | $71.10M | $66.90M | $77.20M |
Free Cash Flow OCF − CapEx | Not available | $-42.70M | $-9.30M | $-31.90M | $-47.00M |
Shares Outstanding | Not available | 17.82M | 17.65M | 17.62M | 17.77M |